Delaware’s Cannabis Debut Surges Past $900K Outpacing Expectations in Just One Weekend

Delaware’s cannabis market exploded past $900K in one weekend, crushing projections and proving skeptics wrong about East Coast demand.

Despite Legalization Push, DEA Still Seizes 5.3 Million Cannabis Plants and Makes 6,000 Arrests

Despite widespread legalization efforts, the DEA seized 5.3 million cannabis plants and arrested nearly 6,000 people in 2024. Federal crackdowns continue escalating.

Study: Marijuana May Temporarily Ease PTSD Symptoms in Veterans, Even as Debate Rages On

Cannabis shows promise for veteran PTSD relief, but clinical trials reveal a shocking gap between patient reports and scientific evidence.

ATA Raises Alarm Over Cannabis Rescheduling’s Threat to Trucking Safety Standards

ATA warns cannabis rescheduling could eliminate mandatory drug testing for truckers, threatening highway safety as marijuana violations surge nationwide.

How Readypaid Is Transforming Cannabis B2B Payments With Automated Buy Now, Pay Later Innovation

ReadyPaid eliminates $4 billion in unpaid cannabis receivables with instant B2B payments while traditional banks ignore 95% of the industry.

New York’s Cannabis Tracking System Stalls Amid Vendor Merger Chaos

BioTrack’s merger with Metrc triggers chaos across New York’s cannabis industry, exposing dangerous market vulnerabilities that threaten regulatory compliance statewide.

How Canada’s Cannabis Industry Quietly Outgrew Breweries and Created 80,000+ Jobs

Canada’s cannabis industry silently crushed breweries while generating 93,465+ jobs and $9.1 billion GDP impact. The transformation happened faster than anyone predicted.

Minnesota’s Cannabis Market Nears Launch, Will Tribal Dispensaries Keep Leading the Pack?

Minnesota’s tribal dispensaries dominate the new cannabis market while state-licensed competitors face caps and delays. Who will control this billion-dollar industry?

Trump Mulls Downgrading Federal Marijuana Risk in Possible Historic Policy Shift

Trump’s potential marijuana rescheduling could shatter decades of federal drug policy while transforming a $30 billion industry overnight.

Vaporized Cannabis Shows Migraine Relief in First Placebo-Controlled Human Trial

First rigorous human trial proves vaporized cannabis dramatically outperforms placebo for migraine relief, challenging decades of pharmaceutical-only treatment approaches.